These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24395452)

  • 1. Molecular monitoring.
    Soverini S; Rosti G; Baccarani M; Martinelli G
    Curr Hematol Malig Rep; 2014 Mar; 9(1):1-8. PubMed ID: 24395452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative BCR-ABL1 RQ-PCR fusion transcript monitoring in chronic myelogenous leukemia.
    Moore FR; Rempfer CB; Press RD
    Methods Mol Biol; 2013; 999():1-23. PubMed ID: 23666687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular monitoring and mutations in chronic myeloid leukemia: how to get the most out of your tyrosine kinase inhibitor.
    Baccarani M; Soverini S; De Benedittis C
    Am Soc Clin Oncol Educ Book; 2014; ():167-75. PubMed ID: 24857074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
    Scott S; Cartwright A; Francis S; Whitby L; Sanzone AP; Mulder A; Galimberti S; Dulucq S; Mauté C; Lauricella C; Salmon M; Rose S; Willoughby J; Boeckx N; Pallisgaard N; Maier J; Leibundgut EO; Zizkova H; Ling Goh L; Duong C; Tang WF; Ma E; Shivakumar Y; Beppu L; Bhagavatula P; Chantry A
    Br J Haematol; 2021 Jul; 194(1):53-60. PubMed ID: 34114218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring BCR-ABL in the treatment of chronic myeloid leukemia by polymerase chain reaction.
    Oehler VG; Radich JP
    Curr Hematol Malig Rep; 2006 Sep; 1(3):152-9. PubMed ID: 20425346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay.
    Goh HG; Lin M; Fukushima T; Saglio G; Kim D; Choi SY; Kim SH; Lee J; Lee YS; Oh SM; Kim DW
    Leuk Lymphoma; 2011 May; 52(5):896-904. PubMed ID: 21338281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Treatment-Free Remission by Droplet Digital PCR in CML Patients with Deep Molecular Response to Tyrosine Kinase Inhibitor: An Analysis Based on Real-World Data.
    Zhu G; Yang Y; Wang H; Xie J; Hu J; Guo W; Zhang L; Liu Z; Chen X; Chang J; Xu J; Tan Y
    Ann Clin Lab Sci; 2020 Sep; 50(5):591-599. PubMed ID: 33067205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction.
    Stentoft J; Pallisgaard N; Kjeldsen E; Holm MS; Nielsen JL; Hokland P
    Eur J Haematol; 2001; 67(5-6):302-8. PubMed ID: 11872078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose modification of imatinib by monitoring the level of BCR-ABL transcript in chronic myelogenous leukemia.
    Ishikawa I; Kato C; Harigae H; Sugawara T; Tomiya Y; Yamada M; Ishizawa K; Kameoka J; Miyamura K; Sasaki T
    Tohoku J Exp Med; 2006 Dec; 210(4):355-63. PubMed ID: 17146202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR-ABL PCR testing in chronic myelogenous leukemia: molecular diagnosis for targeted cancer therapy and monitoring.
    Luu MH; Press RD
    Expert Rev Mol Diagn; 2013 Sep; 13(7):749-62. PubMed ID: 24063401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular monitoring of chronic myeloid leukemia: present and future.
    Yeung CC; Egan D; Radich JP
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1083-1091. PubMed ID: 27552202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of childhood chronic myelogenous leukemia with monitoring the BCR-ABL fusion gene expression in peripheral blood.
    Horváth A; Baghiu MD; Pap Z; Bănescu C; Mărginean CO; Pávai Z
    Rom J Morphol Embryol; 2011; 52(3):907-13. PubMed ID: 21892537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation.
    Bernardi S; Malagola M; Zanaglio C; Polverelli N; Dereli Eke E; D'Adda M; Farina M; Bucelli C; Scaffidi L; Toffoletti E; Deambrogi C; Stagno F; Bergamaschi M; Franceschini L; Abruzzese E; Divona MD; Gobbi M; Di Raimondo F; Gaidano G; Tiribelli M; Bonifacio M; Cattaneo C; Iurlo A; Russo D
    Cancer Med; 2019 May; 8(5):2041-2055. PubMed ID: 30950237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular monitoring of Tunisian patients with chronic myeloid leukemia.
    Menif S; Ben Youssef Y; Bellaaj H; Ben Lakhal R; Laatiri A
    Tunis Med; 2017 Dec; 95(12):229-231. PubMed ID: 29878287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of BCR-ABL fusion proteins in patients with leukemia using a cytometric bead array.
    Yujie W; Yu Z; Sixuan Q; Li W; Peng L; Zeng G; Sujiang Z; Jianyong L
    Leuk Lymphoma; 2012 Mar; 53(3):451-5. PubMed ID: 21933042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR].
    Larripa I; Ruiz MS; Gutiérrez M; Bianchini M
    Medicina (B Aires); 2017; 77(1):61-72. PubMed ID: 28140313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial treatment for patients with CML.
    Goldman JM
    Hematology Am Soc Hematol Educ Program; 2009; ():453-60. PubMed ID: 20008231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Detection of BCR-ABL in Chronic Myeloid Leukemia.
    Qin YZ; Huang XJ
    Methods Mol Biol; 2016; 1465():1-15. PubMed ID: 27581134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.